Inventor · disambiguated record
Barbara J. Brandhuber
Also filed as: BRANDHUBER BARBARA J · BRANDHUBER BARBARA JEAN
31 granted patents·5 pending applications·98 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
36 records- 0198US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0297US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 0397US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 0496US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 0594US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 0691US10907215B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2018·Granted Feb 2, 2021·3 cites·27 claims
- 0791US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 0890US10724102B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2016·Granted Jul 28, 2020·3 cites·44 claims
- 0990US10655186B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted May 19, 2020·3 cites·14 claims
- 1089US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 1188US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 1287US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 1385US10378068B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted Aug 13, 2019·3 cites·20 claims
- 1485US10370727B2Point mutations in TRK inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2017·Granted Aug 6, 2019·3 cites·20 claims
- 1584US9896435B2N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Feb 20, 2018·3 cites·29 claims
- 1682US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 1780US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 1878US12268666B2Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2024·Granted Apr 8, 2025·0 cites·8 claims
- 1976US7144988B2Method of structure-based drug design to create or improve modulators of IL-1 activity which bind to the interleukin-1 type 1 receptorARRAY BIOPHARMA INC·Filed 2003·Granted Dec 5, 2006·1 cites·4 claims
- 2076US2021186959A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2175US2021164055A1Point mutations in trk inhibitor-resistant cancer and methods relating to the sameLOXO ONCOLOGY INC·Filed 2021·Application pending·0 cites
- 2272US11648243B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted May 16, 2023·0 cites·20 claims
- 2370US10351575B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2013·Granted Jul 16, 2019·1 cites·48 claims
- 2468US9546156B2N-bicyclic aryl,N'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Jan 17, 2017·1 cites·25 claims
- 2564US2025186400A1Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 2663US10889589B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2019·Granted Jan 12, 2021·0 cites·34 claims
- 2762US12109193B2Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamideLOXO ONCOLOGY INC·Filed 2019·Granted Oct 8, 2024·0 cites·6 claims
- 2859US10851080B2Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 2953US9969694B2N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted May 15, 2018·0 cites·1 claims
- 3053US9790178B2Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 17, 2017·0 cites·6 claims
- 3152US9981959B2Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted May 29, 2018·0 cites·4 claims
- 3247US9809578B2Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as trkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 7, 2017·0 cites·18 claims
- 3346US2022251096A17,8-DIHYDRO-4H-PYRAZOLO[4,3-c]AZEPINE-6-ONE COMPOUNDSLILLY CO ELI·Filed 2020·Application pending·0 cites
- 3445US9822118B2Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 21, 2017·0 cites·6 claims
- 3545US9790210B2N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 17, 2017·0 cites·10 claims
- 3644US9828360B2Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 28, 2017·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →